UNITED THERAPEUTICS Corp Insider Trading for March 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in UNITED THERAPEUTICS Corp.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in UNITED THERAPEUTICS Corp for March 2017.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 31 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Option Exercise | M | 30.75 | 947 | 29,120 | 76,178 | |
Mar 31 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Option Exercise | M | 30.75 | 1,230 | 37,823 | 77,125 | |
Mar 31 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Buy | M | 30.75 | 947 | 29,120 | 651,109 | 650.2 K to 651.1 K (+0.15 %) |
Mar 31 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Sell | S | 135.27 | 230 | 31,111 | 140 | 370 to 140 (-62.16 %) |
Mar 31 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Sell | S | 134.57 | 900 | 121,116 | 370 | 1.3 K to 370 (-70.87 %) |
Mar 31 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Sell | S | 132.82 | 100 | 13,282 | 1,270 | 1.4 K to 1.3 K (-7.30 %) |
Mar 31 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Buy | M | 30.75 | 1,230 | 37,823 | 1,370 | 140 to 1.4 K (+878.57 %) |
Mar 27 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Option Exercise | M | 30.75 | 957 | 29,428 | 78,355 | |
Mar 27 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Option Exercise | M | 30.75 | 1,219 | 37,484 | 79,312 | |
Mar 27 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Buy | M | 30.75 | 957 | 29,428 | 650,162 | 649.2 K to 650.2 K (+0.15 %) |
Mar 27 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Sell | S | 139.86 | 500 | 69,930 | 140 | 640 to 140 (-78.12 %) |
Mar 27 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Sell | S | 138.96 | 719 | 99,912 | 640 | 1.4 K to 640 (-52.91 %) |
Mar 27 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Buy | M | 30.75 | 1,219 | 37,484 | 1,359 | 140 to 1.4 K (+870.71 %) |
Mar 23 2017 | UTHR | UNITED THERAPEUTIC ... | Thompson Tommy G | Director | Option Exercise | M | 54.77 | 2,000 | 109,540 | 13,000 | |
Mar 23 2017 | UTHR | UNITED THERAPEUTIC ... | Thompson Tommy G | Director | Sell | S | 139.37 | 2,000 | 278,740 | 0 | 2 K to 0 (-100.00 %) |
Mar 23 2017 | UTHR | UNITED THERAPEUTIC ... | Thompson Tommy G | Director | Buy | M | 54.77 | 2,000 | 109,540 | 2,000 | 0 to 2 K |
Mar 20 2017 | UTHR | UNITED THERAPEUTIC ... | MAHON PAUL A | EVP & General Couns ... | Option Exercise | M | 51.37 | 6,000 | 308,220 | 38,500 | |
Mar 20 2017 | UTHR | UNITED THERAPEUTIC ... | MAHON PAUL A | EVP & General Couns ... | Sell | D | 139.11 | 6,000 | 834,660 | 35,426 | 41.4 K to 35.4 K (-14.48 %) |
Mar 20 2017 | UTHR | UNITED THERAPEUTIC ... | MAHON PAUL A | EVP & General Couns ... | Buy | M | 51.37 | 6,000 | 308,220 | 41,426 | 35.4 K to 41.4 K (+16.94 %) |
Mar 20 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Option Exercise | M | 30.75 | 959 | 29,489 | 80,531 | |
Mar 20 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Option Exercise | M | 30.75 | 1,218 | 37,454 | 81,490 | |
Mar 20 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Buy | M | 30.75 | 959 | 29,489 | 649,205 | 648.2 K to 649.2 K (+0.15 %) |
Mar 20 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Sell | S | 144.16 | 100 | 14,416 | 140 | 240 to 140 (-41.67 %) |
Mar 20 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Sell | S | 141.87 | 200 | 28,374 | 240 | 440 to 240 (-45.45 %) |
Mar 20 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Sell | S | 140.62 | 300 | 42,185 | 440 | 740 to 440 (-40.54 %) |
Mar 20 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Sell | S | 139.27 | 300 | 41,780 | 740 | 1 K to 740 (-28.85 %) |
Mar 20 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Sell | S | 138.22 | 318 | 43,954 | 1,040 | 1.4 K to 1 K (-23.42 %) |
Mar 20 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Buy | M | 30.75 | 1,218 | 37,454 | 1,358 | 140 to 1.4 K (+870.00 %) |
Mar 15 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Option Exercise | A | 146.03 | 240,000 | 35,047,200 | 240,000 | |
Mar 15 2017 | UTHR | UNITED THERAPEUTIC ... | MAHON PAUL A | EVP & General Couns ... | Option Exercise | A | 146.03 | 75,000 | 10,952,250 | 75,000 | |
Mar 15 2017 | UTHR | UNITED THERAPEUTIC ... | EDGEMOND JAMES | CFO and Treasurer | Option Exercise | A | 146.03 | 45,000 | 6,571,350 | 45,000 | |
Mar 15 2017 | UTHR | UNITED THERAPEUTIC ... | BENKOWITZ MICHAEL | President and COO | Option Exercise | A | 146.03 | 63,000 | 9,199,890 | 63,000 | |
Mar 13 2017 | UTHR | UNITED THERAPEUTIC ... | PATUSKY CHRISTOPHER | Director | Option Exercise | M | 48.11 | 3,000 | 144,330 | 0 | |
Mar 13 2017 | UTHR | UNITED THERAPEUTIC ... | PATUSKY CHRISTOPHER | Director | Sell | D | 146.44 | 3,000 | 439,320 | 0 | 3 K to 0 (-100.00 %) |
Mar 13 2017 | UTHR | UNITED THERAPEUTIC ... | PATUSKY CHRISTOPHER | Director | Buy | M | 48.11 | 3,000 | 144,330 | 3,000 | 0 to 3 K |
Mar 13 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Option Exercise | M | 30.75 | 970 | 29,828 | 82,708 | |
Mar 13 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Option Exercise | M | 30.75 | 1,206 | 37,085 | 83,678 | |
Mar 13 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Buy | M | 30.75 | 970 | 29,828 | 648,246 | 647.3 K to 648.2 K (+0.15 %) |
Mar 13 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Sell | S | 147.85 | 200 | 29,570 | 140 | 340 to 140 (-58.82 %) |
Mar 13 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Sell | S | 146.91 | 700 | 102,837 | 340 | 1 K to 340 (-67.31 %) |
Mar 13 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Sell | S | 145.56 | 306 | 44,542 | 1,040 | 1.3 K to 1 K (-22.73 %) |
Mar 13 2017 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Buy | M | 30.75 | 1,206 | 37,085 | 1,346 | 140 to 1.3 K (+861.43 %) |
Mar 03 2017 | UTHR | UNITED THERAPEUTIC ... | CAUSEY CHRISTOPHER | Director | Option Exercise | M | 54.77 | 750 | 41,078 | 12,750 | |
Mar 03 2017 | UTHR | UNITED THERAPEUTIC ... | CAUSEY CHRISTOPHER | Director | Option Exercise | M | 51.77 | 500 | 25,885 | 1,500 | |
Mar 03 2017 | UTHR | UNITED THERAPEUTIC ... | CAUSEY CHRISTOPHER | Director | Sell | D | 147.19 | 750 | 110,393 | 975 | 1.7 K to 975 (-43.48 %) |
Mar 03 2017 | UTHR | UNITED THERAPEUTIC ... | CAUSEY CHRISTOPHER | Director | Buy | M | 54.77 | 750 | 41,078 | 1,725 | 975 to 1.7 K (+76.92 %) |
Mar 03 2017 | UTHR | UNITED THERAPEUTIC ... | CAUSEY CHRISTOPHER | Director | Sell | D | 147.19 | 500 | 73,595 | 975 | 1.5 K to 975 (-33.90 %) |
Mar 03 2017 | UTHR | UNITED THERAPEUTIC ... | CAUSEY CHRISTOPHER | Director | Buy | M | 51.77 | 500 | 25,885 | 1,475 | 975 to 1.5 K (+51.28 %) |
Mar 03 2017 | UTHR | UNITED THERAPEUTIC ... | MAHON PAUL A | EVP & General Couns ... | Option Exercise | M | 51.37 | 6,000 | 308,220 | 44,500 | |
Mar 03 2017 | UTHR | UNITED THERAPEUTIC ... | MAHON PAUL A | EVP & General Couns ... | Sell | D | 147.19 | 6,000 | 883,140 | 35,221 | 41.2 K to 35.2 K (-14.56 %) |
Mar 03 2017 | UTHR | UNITED THERAPEUTIC ... | MAHON PAUL A | EVP & General Couns ... | Buy | M | 51.37 | 6,000 | 308,220 | 41,221 | 35.2 K to 41.2 K (+17.04 %) |